These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2881819)

  • 41. Immune responses to pertussis vaccines concurrently administered with viral vaccines.
    Halperin SA; Eastwood BJ; Langley JM
    Ann N Y Acad Sci; 1995 May; 754():89-96. PubMed ID: 7625684
    [No Abstract]   [Full Text] [Related]  

  • 42. Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: immune response to the first booster following the diphtheria and tetanus toxoids vaccine primary series.
    Pichichero ME; Barkin RM; Samuelson JS
    Pediatr Infect Dis; 1986; 5(4):428-30. PubMed ID: 3487779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double-blind study comparing an acellular pertussis-component DTP vaccine with a whole-cell pertussis-component DTP vaccine in 18-month-old children.
    Lewis K; Cherry JD; Holroyd HJ; Baker LR; Dudenhoeffer FE; Robinson RG
    Am J Dis Child; 1986 Sep; 140(9):872-6. PubMed ID: 2874738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunogenicity of a Haemophilus influenzae type b vaccine in combination with diphtheria-pertussis-tetanus vaccine in infants.
    Coulehan JL; Hallowell C; Michaels RH; Welty TK; Lui N; Kuo JS
    J Infect Dis; 1983 Sep; 148(3):530-4. PubMed ID: 6311913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Why wait for DTP-E-IPV?
    Marcuse EK
    Am J Dis Child; 1989 Sep; 143(9):1006-7. PubMed ID: 2788991
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines.
    Blaskett AC; Cox JC
    Epidemiol Infect; 1988 Jun; 100(3):335-44. PubMed ID: 2897927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children.
    Morgan CM; Blumberg DA; Cherry JD; Reisinger KS; Blatter MM; Blumer JL; Dekker CL; Stout MG; Christenson PD
    Am J Dis Child; 1990 Jan; 144(1):41-5. PubMed ID: 2403747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines.
    Vermeulen F; Verscheure V; Damis E; Vermeylen D; Leloux G; Dirix V; Locht C; Mascart F
    Clin Vaccine Immunol; 2010 Feb; 17(2):258-62. PubMed ID: 20016042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine.
    Robertson SE; Traverso HP; Drucker JA; Rovira EZ; Fabre-Teste B; Sow A; N'Diaye M; Sy MT; Diouf F
    Lancet; 1988 Apr; 1(8591):897-9. PubMed ID: 2895828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of immunogenicity of combined DPT--inactivated injectable polio vaccine (DPT - IPV) and association of DPT and attenuated oral polio vaccine (DPT + OPV) in Pakistani children.
    Qureshi AW; Zulfiqar I; Raza A; Siddiqi N
    J Pak Med Assoc; 1989 Feb; 39(2):31-5. PubMed ID: 2499700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serological evaluation of poliomyelitis oral and inactivated vaccines in an urban low-income population at Rio de Janeiro, Brazil.
    Schatzmayr HG; Maurice Y; Fujita M; de Fillipis AM
    Vaccine; 1986 Jun; 4(2):111-3. PubMed ID: 3014770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccine policy likely to be reassessed in 1990s when polio-DTP combination becomes available.
    Marwick C
    JAMA; 1988 Jun; 259(24):3523-4. PubMed ID: 3259637
    [No Abstract]   [Full Text] [Related]  

  • 53. DTP and DTP-inactivated polio vaccines: comparison of adverse reactions and IGG, IGM and IGA antibody responses to DTP.
    Ruuskanen O; Viljanen MK; Salmi TT; Lehtonen OP; Kouvalainen K; Peltonen T
    Acta Paediatr Scand; 1980 Mar; 69(2):177-82. PubMed ID: 6989154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating immune complexes after DTP immunization.
    Habig WH; Holohan TV; Phillips TM
    J Pediatr; 1988 Jan; 112(1):162-3. PubMed ID: 3257263
    [No Abstract]   [Full Text] [Related]  

  • 55. Two injections of diphtheria-tetanus-pertussis-polio vaccine as the backbone of a simplified immunization schedule in developing countries.
    Cohen H; Nagel J
    Rev Infect Dis; 1984; 6 Suppl 2():S350-1. PubMed ID: 6610910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acellular pertussis vaccines.
    Hinman AR; Onorato IM
    Pediatr Infect Dis J; 1987 Apr; 6(4):341-3. PubMed ID: 3495774
    [No Abstract]   [Full Text] [Related]  

  • 57. [Limited controlled trial of the reactogenic properties of ADTP vaccines containing stab cultures as the pertussis component].
    Shmeleva EI; Remova TN; Baeva EA; Salmin LV; Selezneva VP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):68-73. PubMed ID: 6087580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants.
    Anderson EL; Belshe RB; Bartram J
    J Infect Dis; 1988 Apr; 157(4):731-7. PubMed ID: 2894399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoblot analysis of humoral immune responses following infection with Bordetella pertussis or immunization with diphtheria-tetanus-pertussis vaccine.
    Redd SC; Rumschlag HS; Biellik RJ; Sanden GN; Reimer CB; Cohen ML
    J Clin Microbiol; 1988 Jul; 26(7):1373-7. PubMed ID: 2900846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DTaP-hepatitis B-poliovirus vaccine (SmithKline Beecham). InfanrixDTPa-HepB-IPV.
    Drugs R D; 1999 Sep; 2(3):195-6. PubMed ID: 10641224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.